The manuscript addresses the 3D chromatin architecture in monocytes from patients with alcohol-associated hepatitis and its relationship to enhanced transcription of innate immune genes. While the ...

Stellaromics, a start-up that uses multiomics technology to help researchers understand the spatial organization of cells and tissues, has raised $80 million in a series B financing. Catalyst4, a ...

Please view our affiliate disclosure. In the rapidly evolving world of technology, artificial intelligence (AI) has been a game-changer, especially in the field of 3D object generation. AI-powered 3D ...

31 January 2025 - Oxford BioDynamics PLC (AIM: OBD), a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D genomics platform announces that the resolutions ...

Enhanc3D Genomics (‘Enhanced’), an innovator in 3D genomics technology, today announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of ...

Enhanc3D Genomics launched a suite of 3D multi-omics solutions to accelerate drug development during a presentation at last week’s Biotech Showcase, part of JPM Week in San Francisco. They are based ...

Oxford BioDynamics is developing precision medicine tests based on the EpiSwitch 3D genomics platform and, in a statement on January 15, said that the net proceeds would provide additional working ...

Bio-Rad Laboratories, Inc. (CA, USA) a global leader in life science research and clinical diagnostics products, today announced the launch of Nuvia wPrime 2A Media, a scalable weak anion exchange and ...

The biotech is developing precision medicine tests based on the EpiSwitch 3D genomics platform and, in a statement, said that the net proceeds would provide additional working capital and cash runway ...